Lodoxamide Tromethamine

CHEMBL3989725 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

553.9 g/mol

LogP

—

Phase

4

The tromethamine salt form of lodoxamide, used in ophthalmic solutions for allergic eye conditions. It shares the mast cell stabilizing properties of the parent compound in its pharmaceutical preparation.

분자량

553.9000 g/mol

TPSA

330.00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1.NC(CO)(CO)CO.NC(CO)(CO)CO

InChI

InChI=1S/C11H6ClN3O6.2C4H11NO3/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21;2*5-4(1-6,2-7)3-8/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21);2*6-8H,1-3,5H2

Molecular Formula

C19H28ClN5O12

HBD / HBA

12 / 15

회전 가능 결합

10

무거운 원자

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

The tromethamine salt form of lodoxamide, used in ophthalmic solutions for allergic eye conditions. It shares the mast cell stabilizing properties of the parent compound in its pharmaceutical preparation.

Yes, Lodoxamide Tromethamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989725. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11192129. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Lodoxamide Tromethamine PillFYI에서

구조

핵심 데이터

분자식: C19H28ClN5O12

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.